Dr Mohammed S Salahudeen

Has grant

Senior Lecturer in Clinical Pharmacy and Lead Graduate Research Coordinator

University of Tasmania
Country flagAustralia

Research Interests

Explore related searches

About

Dr. Mohammed S. Salahudeen is a Senior Lecturer in Clinical Pharmacy and the Lead Graduate Research Coordinator at the University of Tasmania, Australia. His research areas include pharmacoepidemiology, adverse drug reactions, and the optimization of pharmacotherapy in older adults. Recent publications reflect his commitment to improving pharmacy education and clinical practices through insights on simulation in education and systematic reviews on medication management.

Recent Grants

Grant: Close

Hospitalisation as an opportunity to optimise anticoagulant treatment in patients with atrial fibrillation

Open Date: 2023-01-01

Close Date:

Grant: Close

Intervention to lessen anticholinergic drug burden in hospitalised older adults

Open Date: 2022-01-01

Close Date: 2022-01-01

Grant: Close

Adverse drug reaction-related hospital admission in elderly Australians with dementia

Open Date: 2020-01-01

Close Date: 2020-01-01

Grant: Close

Travel Grant for attending international conference

Open Date: 2017-07-01

Close Date: 2017-12-01

Grant: Close

Risks associated with polypharmacy and hyper-polypharmacy in older individuals using the interRAI data

Open Date: 2016-08-01

Close Date:

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Limited data are available regarding adverse drug reactions (ADRs) and medication-related hospitalisations or emergency department (ED) visits in older adults with diabetes, especially since the emergence of newer antidiabetic agents. This systematic review aimed to explore the nature of hospital admissions and ED visits that are medication-related in older adults with diabetes. The review was conducted according to the PRISMA guidelines. Studies in English that reported on older adults (mean age ≥ 60 years) with diabetes admitted to the hospital or presenting to ED due to medication-related problems and published between January 2000 and October 2023 were identified using Medline, Embase, and International Pharmaceutical Abstracts databases. Thirty-five studies were included. Medication-related hospital admissions and ED visits were all reported as episodes of hypoglycaemia and were most frequently associated with insulins and sulfonylureas. The studies indicated a decline in hypoglycaemia-related hospitalisations or ED presentations in older adults with diabetes since 2015. However, the associated medications remain the same. This finding suggests that older patients on insulin or secretagogue agents should be closely monitored to prevent potential adverse events, and newer agents should be used whenever clinically appropriate.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Jan Radford

Prof in General Practice

University of Tasmania

AUSTRALIA
View details

Woldesellassie M. Bezabhe

University of Tasmania

AUSTRALIA
View details

Viet Tran

-

AUSTRALIA
View details

Gregory M. Peterson

-

AUSTRALIA
View details

Corinne Mirkazemi

Lecturer in Therapeutics and Pharmacy Practice

University of Tasmania

AUSTRALIA
View details

Luke Bereznicki

Associate Professor of Pharmacy Practice

University of Tasmania

AUSTRALIA
View details

Colin Curtain

University of Tasmania

AUSTRALIA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.